REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku Profile Updated: June 04, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku is a high-specialist facility located in Bialystok, Poland. The company focuses on the recognition and treatment of cancer diseases, offering radiation therapy, laboratory diagnostics, and cancer registration services.

Headquarters
Ul. Ogrodowa 12
Bialystok; Podlaskie; Postal Code: 15-027

Contact Details: Purchase the Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku report to view the information.

Website: http://www.onkologia.bialystok.pl

Basic Information
Total Employees:
Purchase the Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku report to view the information.
Outstanding Shares:
Purchase the Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku report to view the information.
Financial Auditors:
Purchase the Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku report to view the information.
Incorporation Date:
March 21, 2001
Key Executives
Purchase this report to view the information.
Kierownik Samodzielnego Publicznego Zakladu Opieki Zdrowotnej
Company Performance
Financial values in the chart are available after Bialostockie Centrum Onkologii Im. M. Sklodowskiej-Curie W Bialymstoku report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
16.85%▲
Total operating revenue
16.28%▲
Operating profit (EBIT)
13.33%▲
EBITDA
10.89%▲
Net Profit (Loss) for the Period
12.63%▲
Total assets
5%▲
Total equity
9.99%▲
Operating Profit Margin (ROS)
-0.12%▼
Net Profit Margin
-0.14%▼
Return on Equity (ROE)
0.16%▲
Quick Ratio
0.13%▲
Cash Ratio
-0.15%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo